Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
Sanofi’s new CEO Garijo outlines an R&D restructuring and expansion plan as the company balances strong second-quarter earnings against investor concerns.
19 independently checked trend briefs about this subject, newest first.
headlinez.news detected 19 source-qualified news clusters connected to M&A between June 23, 2026 and July 30, 2026. They span 2 newsroom categories and average 7.5 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
Sanofi’s new CEO Garijo outlines an R&D restructuring and expansion plan as the company balances strong second-quarter earnings against investor concerns.
A $2.2 billion acquisition agreement marks a significant shift in the immunology market, as Argenx moves to absorb Forte Biosciences.
Reports indicate United Airlines previously sought to merge with Delta and American, signaling a potential shift in major airline consolidation strategy.
Brookfield and CPP Investments have agreed to acquire LXP Industrial Trust in a transaction valued at $5.2 billion.
Netflix has confirmed the acquisition of Ben Affleck’s artificial intelligence startup, InterPositive, for $587 million.
Lionsgate Studios shares have surged following reports of potential takeover interest from European media groups.
Bank of America is doubling down on middle-market deals with a wave of senior hires—just before earnings season
A $53B+ bid for PayPal reshapes fintech’s next chapter—who’s behind it and what’s at stake?
Vertex Pharmaceuticals announces a $10 billion acquisition of Crinetics Pharmaceuticals, marking its largest deal to date and an entry into endocrinology.
Vertex Pharmaceuticals has announced a $10 billion acquisition of Crinetics, signaling a significant shift in the biopharma landscape.
French shipping giant CMA CGM is set to acquire FedEx Supply Chain for $1.4 billion, marking a significant consolidation in global logistics.
Schneider Electric is set to acquire industrial AI firm Cognite in a transaction valued at $3.1 billion.
Ipsen’s $1.75B bid for Kartos Therapeutics reshapes blood cancer drug development—with a twist on the deal’s structure
CVC Capital Partners expands its food ingredients portfolio with the acquisition of Italy’s IRCA from Advent International
Comcast announces the spin-off of NBCUniversal, sparking industry-wide analysis on regulatory hurdles, potential mergers, and the impact on Sky.
Korn Ferry has entered into a definitive agreement to acquire the UK-based recruitment firm AMS.
Rocket Lab’s $8B Iridium buyup reshapes space economy—beyond rockets, into satellite networks
Merck KGaA, Darmstadt, Germany, has entered into an $11.3 billion agreement to acquire Minneapolis-based life sciences firm Bio-Techne.
AbbVie’s $10.9B bid for Apogee Therapeutics reshapes biotech M&A landscape overnight